[Microsurgical resection of glioblastoma guided with intraoperative fluorescein: a Retrospective evaluation]. 2015

Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú

OBJECTIVE To evaluate the influence of the use of sodium fluorescein (FLS-Na) in surgery of glioblastoma (GB) on the degree of tumor resection and survival in patients treated at the National Institute of Neoplastic Diseases. METHODS A total of 238 cases of GB treated between 2008 and 2013 were reviewed and 150 cases of GB who underwent surgical resection with clinicopathological information and adequate follow-up were selected. RESULTS The mean age was 51 years, 58.7% of the cases presented a Karnofsky score of at least 90. FLS-Na was administered in 80 cases (53.3%) and a subtotal and total resection was obtained in 69 (46%) and 81 (54%) cases, respectively. The group that received FLS-Na obtained higher rates of total resection than the group operated with white light alone (77.5 vs 27.1%, p<0.001). The median overall survival (OS) was higher in the group subject to total compared to subtotal resection (17 vs 7 months, p<0.001). The median OS in those who received FLS-Na was higher than in those who did not (15.0 vs 8 months, p=0.003). Other factors affecting OS were age (p=0.002), the Karnofsky score (p=0.052) and radiation therapy (p=0.016) and chemotherapy (p=0.011). CONCLUSIONS The microsurgical technique with administration of FLS-Na was associated with an increase in the rate of total resection and survival.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D019793 Fluorescein A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor. Fluorescein Sodium,Sodium Fluorescein,C.I. 45350,Colircusi Fluoresceina,D & C Yellow No. 7,D & C Yellow No. 8,D and C Yellow No. 7,D and C Yellow No. 8,D&C Yellow No. 7,D&C Yellow No. 8,Diofluor,Disodium Fluorescein,Fluor-I-Strip A.T.,Fluorescein Dipotassium Salt,Fluorescein Disodium Salt,Fluorescein Monosodium Salt,Fluorescite,Fluorescéine sodique Faure,Fluorets,Ful-Glo,Funduscein,Minims Fluorescein Sodium,Minims Fluoresceine,Minims Stains,Optifluor Diba,Uranine,Dipotassium Salt, Fluorescein,Disodium Salt, Fluorescein,Fluor I Strip A.T.,Fluorescein Sodium, Minims,Fluorescein, Disodium,Fluorescein, Sodium,Fluoresceina, Colircusi,Fluoresceine, Minims,Ful Glo,Monosodium Salt, Fluorescein,Sodium, Fluorescein

Related Publications

Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
August 2018, Zhonghua wai ke za zhi [Chinese journal of surgery],
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
January 2022, Neurosurgical focus: Video,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
October 2011, The Lancet. Oncology,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
December 2018, Clinical neurology and neurosurgery,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
February 2008, British journal of neurosurgery,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
October 2019, Neurosurgical focus: Video,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
May 2017, The New England journal of medicine,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
July 2017, Journal of neurosurgery,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
December 2022, Journal of clinical medicine,
Pamela García-Corrochano, and Carlos A Castañeda, and Enrique Orrego, and Pedro Deza, and Hugo Heinicke, and Sandro Casavilca, and Miluska Castillo, and Karen Cortez, and Carolina Belmar, and Ketty Dolores, and Claudio Flores, and Luis Ojeda
August 2017, World neurosurgery,
Copied contents to your clipboard!